Growth Metrics

Avadel Pharmaceuticals (AVDL) Shares Outstanding (Diluted Average): 2009-2020

Historic Shares Outstanding (Diluted Average) for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2020 value amounting to $54.9 million.

  • Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) rose 46.89% to $54.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was $54.9 million, marking a year-over-year increase of 46.89%. This contributed to the annual value of $54.9 million for FY2020, which is 46.89% up from last year.
  • According to the latest figures from Q4 2020, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) is $54.9 million, which was down 5.62% from $58.2 million recorded in Q3 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) registered a high of $69.9 million during Q2 2020, and its lowest value of $37.3 million during Q4 2018.
  • In the last 3 years, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) had a median value of $37.4 million in 2019 and averaged $44.0 million.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) surged by 102,100.58% in 2016, and later dropped by 11.63% in 2018.
  • Over the past 5 years, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarterly) stood at $41.2 million in 2016, then rose by 1.25% to $41.8 million in 2017, then declined by 10.63% to $37.3 million in 2018, then rose by 0.21% to $37.4 million in 2019, then surged by 46.89% to $54.9 million in 2020.
  • Its last three reported values are $54.9 million in Q4 2020, $58.2 million for Q3 2020, and $69.9 million during Q2 2020.